Yu Wu – Trademark Portfolio
Entity Type: 01
Yu Wu owns a portfolio of 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as LUCKSUN, SPIHIME, TASANOL, NIUDYBIG, and PHILPETY. Of these, 5 are registered and 2 are pending. The portfolio spans 6 Nice Classification classes, led by Class 9 (Computers & Electronics) and Class 21 (Housewares). Headquartered in Shenzhen.
Sanlian Community, Longhua
C01, 4/F, No. 110 Qingquan Rd.
Shenzhen 518000 , CN
Showing of trademarks Trademarks
Trademark Classifications
Yu Wu's trademark portfolio spans 6 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Apparatus for lighting, heating, steam generating, cooking, refrigerating, drying
Leather and imitations of leather; animal skins, hides; trunks and travelling bags
Industrial oils and greases; lubricants; dust absorbing, wetting and binding compositions
Frequently Asked Questions
How many trademarks does Yu Wu have?
Yu Wu has 9 U.S. trademarks filed with the USPTO. Of these, 5 registered, 2 pending, 1 abandoned.
What trademark classes does Yu Wu file in?
Yu Wu files trademarks across 6 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 21 (Housewares), Class 25 (Clothing), Class 11 (Environmental Control), Class 18 (Leather Goods). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are Yu Wu's most well-known trademarks?
Yu Wu's registered trademark portfolio includes well-known marks such as LUCKSUN, SPIHIME, TASANOL, NIUDYBIG, and PHILPETY. These are among 5 currently registered trademarks in the portfolio.
What is Yu Wu's trademark registration success rate?
Yu Wu has a 83% trademark registration rate, with 5 out of 6 resolved applications resulting in successful registration. Currently, 2 applications are pending review.